the beneficial effects of a combination of aspirin and dipyridamole in slowing the deterioration of renal function in patients with membranoproliferative glomerulonephritis does provide a rationale for exploring the effects of low-dose aspirin ( i.e. , 0.5 to 1.0 mg/kg per day ) , which most effectively suppresses platelet thromboxane a2 production without interfering with renal prostacyclin synthesis .
C0017662
membranoproliferative glomerulonephritis
C0022646
renal